Stock Markets August 6, 2026 12:46 PM

Protein Coffee Maker Javvy Weighs Sale as Protein Demand Climbs

South Carolina-based Javvy has enlisted Houlihan Lokey for an early-stage sale process that could value the company near $1 billion amid rising interest in protein-forward beverages

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn

Javvy, the producer of caffeinated protein coffee powders and concentrates, is conducting an early-stage sale process that could place its valuation around $1 billion. The South Carolina firm, generating nearly $300 million in annual sales, has hired Houlihan Lokey, according to people familiar with the matter. Javvy’s product lineup and recent retail expansion have coincided with broader industry moves toward protein-enriched and functional beverages.

Protein Coffee Maker Javvy Weighs Sale as Protein Demand Climbs
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Javvy has hired Houlihan Lokey for an early-stage sale process that could value the company near $1 billion - impacts M&A and private equity activity in consumer goods.
  • The South Carolina-based firm reports nearly $300 million in annual revenue and recently expanded retail distribution into Walmart, Target, Sprouts and other chains - relevant to retail and grocery sectors.
  • Javvy’s product lineup centers on protein-forward coffee powders and related products, reflecting broader industry interest in functional beverages - affecting food and beverage product strategy.

Javvy, the maker of protein-enriched coffee powders and concentrates, is pursuing a potential sale that sources say could value the business at roughly $1 billion. People familiar with the discussions said the company has engaged investment bank Houlihan Lokey to run a sale process that remains at an early stage, and those sources requested anonymity to discuss a private matter.

The South Carolina-headquartered company, which offers caffeinated mix-with-water powders and coffee concentrates in flavors such as Dubai chocolate, banana bread and tiramisu, reported nearly $300 million in annual revenue, according to the people. Javvy had not provided comments to requests for comment, and Houlihan Lokey declined to comment.


Javvy’s product formulation is pitched as both functional and convenient. Each serving of its powder delivers 10 grams of protein and includes prebiotics for gut support as well as medium-chain triglycerides that the company says support brain health. The brand’s portfolio extends beyond powdered mixes to include protein refreshers, coffee syrups and creamers.

The company was founded in 2020 by entrepreneurs Justin Kemperman and Brandon Monaghan. Javvy expanded its retail footprint recently, launching in Walmart stores last month and selling products at Target, Sprouts Farmers Market and other supermarket and pharmacy chains.


Venture capital firms including Amberstone Ventures, Platinum Mile Ventures and Selva Ventures have backed the business. Company communications last month noted that Javvy had reached about one in every 44 U.S. households, and that one Javvy Protein Coffee product is sold every seven to eight seconds, the people said. On Javvy’s website, a single 20-serving bag is listed at $34.95.

The potential sale comes as consumer packaged goods companies seek to capture growing demand for protein-rich and other functional offerings. Major food and beverage firms have broadened their protein selections; for example, Starbucks added protein lattes and protein cold foams to its menu last year and this year introduced ready-to-drink protein coffee beverages online and into grocery and convenience channels.

Market participants described the transaction process as preliminary. The early-stage nature of the engagement and the lack of public comment from the company and its adviser underscore uncertainties about timing, deal structure and potential bidders.

Javvy’s combination of flavored caffeinated products, expanded retail presence and venture backing have positioned it as one of the growing specialty brands operating in the protein and functional beverage segment. How the sale process unfolds and whether it culminates in a transaction at the reported valuation remain open questions, contingent on a number of factors discussed privately by potential bidders and advisers.

Risks

  • The sale process is at an early stage and details such as timing, structure and potential buyers remain uncertain - this creates execution risk for investors and dealmakers in M&A activity.
  • Javvy and its adviser declined to comment publicly, leaving outcomes and official valuation unconfirmed - this opacity increases informational risk for market participants tracking the transaction.
  • Competition as major food and beverage companies expand protein offerings could pressure market share and growth assumptions for specialized brands like Javvy - a risk for retail and consumer packaged goods sectors.

More from Stock Markets

Why Apple Remains Berkshire Hathaway’s Top Single Holding Aug 7, 2026 Options Traders Brace as CAVA’s Implied Volatility Spikes Ahead of Earnings Aug 7, 2026 PDF Solutions Shares Rise After Q2 Beat, Backlog Expansion and Reaffirmed 2026 Growth Target Aug 7, 2026 ACM Research Shares Jump After Quarter Beats Estimates, Guidance Raised Aug 7, 2026 Corsair Shares Jump After Q2 Beat, Margin Record and Higher Guidance Aug 7, 2026